Tuberculosis Cases Hit 9-Year High

The latest public health data emerging from the Netherlands serves as a sobering reminder that tuberculosis (TB) is far from a relic of the medical past. According to recent figures released by the RIVM on World Tuberculosis Day, the Netherlands has seen TB diagnoses climb to their highest level since 2016. In 2025 alone, 869 people were diagnosed with the disease, marking a 13 percent increase over the previous year. For those of us living in global hubs like New York City, these numbers aren’t just foreign statistics; they are a mirror of the challenges faced by any metropolitan area that serves as a primary gateway for international migration and asylum seekers.

When we look at the macro trends, the drivers of this increase are clear. The RIVM attributes the rise largely to the influx of individuals from countries where tuberculosis remains endemic. The data is particularly striking when looking at recent arrivals; among asylum seekers who had been in the Netherlands for less than six months, the number of diagnoses more than doubled, jumping from 75 patients in 2024 to 161 in 2025. This pattern highlights a critical vulnerability in public health: the intersection of geopolitical instability and infectious disease transmission. In a city like New York, where the boroughs of Queens and the Bronx host diverse immigrant populations, the importance of robust screening protocols cannot be overstated.

The Demographic Blueprint of a Resurgent Infection

The specific geography of the outbreak in the Netherlands provides a roadmap for where health officials demand to focus their attention. Approximately 82 percent of all TB patients in the Netherlands were born outside the country. The highest concentrations of cases were found among individuals from Eritrea (181 cases), followed by Ethiopia (59) and Somalia (54). To put this in a historical perspective, the 2024 data showed a similar trend, with 81 percent of the 768 patients being foreign-born, with Eritrea and Somalia again featuring prominently. This consistency suggests that the risk is not a random spike but a systemic result of migration from high-burden regions.

There is also a fascinating, albeit concerning, correlation with the post-pandemic world. RIVM reports indicate that TB numbers in the Netherlands had reached a low point during the COVID-19 pandemic. As the strict social distancing measures and contact restrictions of the pandemic era were phased out, transmission rates began to climb again. This “rebound effect” suggests that the pandemic temporarily masked the true prevalence of TB by limiting the very human interactions that allow the bacteria to spread. As New Yorkers returned to crowded subways and dense office environments, the same logic applied: the environment became conducive to the spread of respiratory infections once more.

Understanding the Gap Between Infection and Disease

One of the most critical distinctions in these reports is the difference between a tuberculosis infection and the actual disease. In 2025, the Netherlands recorded 1,652 people with TB infections—a 9 percent increase. These individuals carried the bacteria but were not immediately sick. This represents known as latent TB. Whereas only about 10 percent of those with an infection eventually develop the active disease, the risk remains significant. This is why mandatory screening for newcomers from risk countries is so vital; by identifying the infection early, medical professionals can administer preventative treatment, drastically reducing the likelihood that the latent bacteria will ever transition into an active, contagious illness.

On a global scale, the stakes are unimaginably higher. While the Netherlands has the infrastructure to treat TB effectively, the world at large is struggling. Depending on the source, between 1.3 million and 1.5 million people die annually from tuberculosis. Perhaps most heartbreaking is the impact on the youngest populations, with nearly 600 children dying daily from a disease that is entirely preventable and curable if caught in time. This global disparity underscores why organizations like the CDC and the New York City Department of Health and Mental Hygiene must maintain a vigilant posture, ensuring that the “hidden” nature of latent TB does not lead to a community-wide crisis.

For residents of New York City, the lesson here is one of proactive health management. Whether you are a newcomer to the city or have lived here for decades, understanding your risk factors and the availability of screening is the first line of defense. We can learn from the Dutch model of mandatory screening and early intervention to ensure that our own healthcare systems are prepared for the complexities of a globalized population.

Navigating TB Care in New York City

Given my background in analyzing public health trends, if you or a loved one are concerned about TB exposure—especially if you have recently traveled to or emigrated from high-burden regions—you cannot rely on general practitioners alone. You need a specialized team to navigate the diagnostic and treatment pipeline. In the NYC area, you should look for these three specific types of local professionals:

Board-Certified Infectious Disease Specialists

These are the primary architects of your treatment plan. When seeking a specialist, ensure they have specific experience in mycobacterial diseases. Look for providers affiliated with major academic medical centers who are up-to-date on the latest antibiotic regimens and the management of drug-resistant strains.

Public Health Case Managers

TB treatment is a marathon, not a sprint, often requiring months of strict medication adherence. A dedicated case manager, often found through city-funded health clinics, is essential. They ensure “Directly Observed Therapy” (DOT) is implemented correctly, helping patients avoid the dangerous pitfalls of incomplete treatment that lead to drug resistance.

Certified Immigration Health Screeners

For those arriving in the US, a certified screener is the first point of contact. You should look for clinicians who are authorized to perform the specific skin tests (PPD) or blood tests (IGRA) required for official health clearances. They are trained to differentiate between latent infections and active disease in the early stages of entry.

Managing respiratory health in a dense urban environment requires a combination of clinical expertise and community awareness. By staying informed about global trends and utilizing local specialized care, we can prevent a global spike from becoming a local epidemic.

Ready to find trusted professionals? Browse our complete directory of top-rated healthcare providers in the New York City area today.